BMC Medical Genetics
暂无分享,去创建一个
Yi Wang | Wei Huang | Changzheng Dong | Kaiyue Zhang | Beilan Wang | Yan Dong | Min Shen | X. Chu | Yi Wang | C. Dong | Wei Huang | M. Shen | Shi-jie Xu | Xun Chu | Lingling Sun | Qi Hua | Shijie Xu | Beilan Wang | Lingling Sun | Qi Hua | Kai-yue Zhang | Yan Dong | Kai-yue Zhang | Kai-yue Zhang | Kai-yue Zhang
[1] K. Bohren,et al. A M55V Polymorphism in a Novel SUMO Gene (SUMO-4) Differentially Activates Heat Shock Transcription Factors and Is Associated with Susceptibility to Type I Diabetes Mellitus* , 2004, Journal of Biological Chemistry.
[2] K. Migita,et al. Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population. , 2006, The Journal of clinical endocrinology and metabolism.
[3] Judy H. Cho,et al. Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease , 2007, European Journal of Human Genetics.
[4] M. Vanderpump,et al. The Epidemiology of Autoimmune Thyroid Disease , 1999 .
[5] Yusuke Nakamura,et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis , 2003, Nature Genetics.
[6] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[7] S. Pearce,et al. No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves’ disease , 2005, Clinical endocrinology.
[8] S. Rich,et al. Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients , 2003, Journal of Human Genetics.
[9] Yan Zhang,et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. , 2004, Nature genetics.
[10] Sinead B. O'Leary,et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease , 2001, Nature Genetics.
[11] S. Werner. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. , 1977, The Journal of clinical endocrinology and metabolism.
[12] M. Pierer,et al. Association between β2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope , 2008, Annals of the rheumatic diseases.
[13] G. Barbesino,et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. , 2003, American journal of human genetics.
[14] The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis. , 2005, Rheumatology.
[15] J. Ioannidis,et al. Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.
[16] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[17] Yongsoo Park,et al. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes , 2005, Nature Genetics.
[18] R Staden,et al. Automated detection of point mutations using fluorescent sequence trace subtraction. , 1998, Nucleic acids research.
[19] M. Munakata,et al. Molecular-based haplotype analysis of the beta 2-adrenergic receptor gene (ADRB2) in Japanese asthmatic and non-asthmatic subjects. , 2006, Allergology international : official journal of the Japanese Society of Allergology.
[20] Li Jin,et al. Genome-wide scan of Graves' disease: evidence for linkage on chromosome 5q31 in Chinese Han pedigrees. , 2003, The Journal of clinical endocrinology and metabolism.
[21] K. Jażdżewski,et al. beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease. , 2007, International journal of molecular medicine.
[22] S. Sedimbi,et al. SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients , 2007, Genes and Immunity.